147
Views
0
CrossRef citations to date
0
Altmetric
Original Research

An Association of Pediatric Psoriasis with Metabolic Syndrome in Thai Children: 20 Years Retrospective Study

& ORCID Icon
Pages 75-82 | Published online: 29 Jun 2021

References

  • Bronckers IMGJ, Paller AS, West DP, et al. A comparison of psoriasis severity in pediatric patients treated with methotrexate vs biologic agents. JAMA Dermatol. 2020;156(4):384–392. doi:10.1001/jamadermatol.2019.4835
  • Żychowska M, Reich A, Maj J, Jankowska-Konsur A, Szepietowski JC. Impact of childhood psoriasis on caregivers’ quality of life, measured with family dermatology life quality index. Acta Derm Venereol. 2020;100(15):adv00244. doi:10.2340/00015555-3602
  • Salman A, Yucelten AD, Sarac E, Saricam MH, Perdahli-Fis N. Impact of psoriasis in the quality of life of children, adolescents and their families: a cross-sectional study. An Bras Dermatol. 2018;93(6):819–823. doi:10.1590/abd1806-4841.20186981
  • Varni JW, Globe DR, Gandra SR, Harrison DJ, Hooper M, Baumgartner S. Health-related quality of life of pediatric patients with moderate to severe plaque psoriasis: comparisons to four common chronic diseases. Eur J Pediatr. 2012;171(3):485–492. doi:10.1007/s00431-011-1587-2
  • Micali G, Verzì AE, Giuffrida G, Panebianco E, Musumeci ML, Lacarrubba F. Inverse psoriasis: from diagnosis to current treatment options. Clin Cosmet Investig Dermatol. 2019;12:953–959. doi:10.2147/CCID.S189000
  • Caroppo F, Galderisi A, Ventura L, Fortina AB. Metabolic syndrome and insulin resistance in pre-pubertal children with psoriasis. Eur J Pediatr. 2021;180(6):1739–1745. doi:10.1007/s00431-020-03924-w
  • Hunjan MK, Maradit Kremers H, Lohse C, Tollefson M. Association between obesity and pediatric psoriasis. Pediatr Dermatol. 2018;35(5):e304–5. doi:10.1111/pde.13539
  • Augustin M, Glaeske G, Radtke MA, Christophers E, Reich K, Schäfer I. Epidemiology and comorbidity of psoriasis in children. Br J Dermatol. 2010;162(3):633–636. doi:10.1111/j.1365-2133.2009.09593.x
  • Dogra S, Mahajan R. Biologics in pediatric psoriasis - efficacy and safety. Expert Opin Drug Saf. 2018;17(1):9–16. doi:10.1080/14740338.2018.1391787
  • Papp K, Thaçi D, Marcoux D, et al. Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, Phase 3 trial. Lancet Lond Engl. 2017;390(10089):40–49. doi:10.1016/S0140-6736(17)31189-3
  • Kwon HH, Na SJ, Jo SJ, Youn JI. Epidemiology and clinical features of pediatric psoriasis in tertiary referral psoriasis clinic. J Dermatol. 2012;39(3):260–264. doi:10.1111/j.1346-8138.2011.01452.x
  • Paller AS, Schenfeld J, Accortt NA, Kricorian G. A retrospective cohort study to evaluate the development of comorbidities, including psychiatric comorbidities, among a pediatric psoriasis population. Pediatr Dermatol. 2019;36(3):290–297. doi:10.1111/pde.13772
  • Griffiths CEM, van der Walt JM, Ashcroft DM, et al. The global state of psoriasis disease epidemiology: a workshop report. Br J Dermatol. 2017;177(1):e4–7. doi:10.1111/bjd.15610
  • Bronckers IMGJ, Paller AS, van Geel MJ, van de Kerkhof PCM, Seyger MMB. Psoriasis in children and adolescents: diagnosis, management and comorbidities. Paediatr Drugs. 2015;17(5):373–384. doi:10.1007/s40272-015-0137-1
  • Christian Flemming GM, Bussler S, Körner A, Kiess W. Definition and early diagnosis of metabolic syndrome in children. J Pediatr Endocrinol Metab JPEM. 2020;33(7):821–833. doi:10.1515/jpem-2019-0552
  • Weihe P, Weihrauch-Blüher S. Metabolic syndrome in children and adolescents: diagnostic criteria, therapeutic options and perspectives. Curr Obes Rep. 2019;8(4):472–479. doi:10.1007/s13679-019-00357-x
  • Osier E, Wang AS, Tollefson MM, et al. Pediatric psoriasis comorbidity screening guidelines. JAMA Dermatol. 2017;153(7):698–704. doi:10.1001/jamadermatol.2017.0499
  • Dauden E, Blasco AJ, Bonanad C, et al. Position statement for the management of comorbidities in psoriasis. J Eur Acad Dermatol Venereol. 2018;32(12):2058–2073. doi:10.1111/jdv.15177
  • Bhutani T, Kamangar F, Cordoro KM. Management of pediatric psoriasis. Pediatr Ann. 2012;41(1):e1–7. doi:10.3928/00904481-20111209-08
  • Twelves S, Mostafa A, Dand N, et al. Clinical and genetic differences between pustular psoriasis subtypes. J Allergy Clin Immunol. 2019;143(3):1021–1026. doi:10.1016/j.jaci.2018.06.038
  • Fortina AB, Bardazzi F, Berti S, et al. Treatment of severe psoriasis in children: recommendations of an Italian expert group. Eur J Pediatr. 2017;176(10):1339–1354. doi:10.1007/s00431-017-2985-x
  • Eichenfield LF, Paller AS, Tom WL, et al. Pediatric psoriasis: evolving perspectives. Pediatr Dermatol. 2018;35(2):170–181. doi:10.1111/pde.13382
  • Raychaudhuri SP, Gross J. A comparative study of pediatric onset psoriasis with adult onset psoriasis. Pediatr Dermatol. 2000;17(3):174–178. doi:10.1046/j.1525-1470.2000.01746.x
  • Kang BY, O’Haver J, Andrews ID. Pediatric psoriasis comorbidities: screening recommendations for the primary care provider. J Pediatr Health Care. 2021;35(3):337–350.
  • Kittler NW, Cordoro KM. Pediatric psoriasis comorbidities. Skin Ther Lett. 2020;25(5):1–6.
  • Caroppo F, Ventura L, Belloni fortina A. High blood pressure in normal-weight children with psoriasis. Acta Derm Venereol. 2019;99(3):329–330. doi:10.2340/00015555-3076
  • Yamborisut U, Sakamoto N, Visetchart P, Tontisirin K. Central body fat distribution indices in Thai preschool children. Open J Pediatr. 2012;2(1):47–52. doi:10.4236/ojped.2012.21007
  • Onsoi W, Chaiyarit J, Techasatian L. Common misdiagnoses and prevalence of dermatological disorders at a pediatric tertiary care center. J Int Med Res. 2020;48(2):300060519873490. doi:10.1177/0300060519873490